Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Heyman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268Nanjoo Suh, William W Lamph, Andrew L Glasebrook, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Molecular and Cellular Biology|August 5, 2003
Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expressionBrandee L Wagner, Annabel F Valledor, Gang Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligandPatricia J Willy, Ian R Murray, Jing Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscleVamsi K Mootha, Christoph Handschin, Dan Arlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Identification of macrophage liver X receptors as inhibitors of atherosclerosisRajendra K Tangirala, Eric D Bischoff, Sean B Joseph, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5Mark R Herbert, Dana L Siegel, Lena Staszewski, et al.
Endocrinology|November 5, 2005
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Elife|July 14, 2016
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268Nanjoo Suh, William W Lamph, Andrew L Glasebrook, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Molecular and Cellular Biology|August 5, 2003
Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expressionBrandee L Wagner, Annabel F Valledor, Gang Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligandPatricia J Willy, Ian R Murray, Jing Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2004
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscleVamsi K Mootha, Christoph Handschin, Dan Arlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Identification of macrophage liver X receptors as inhibitors of atherosclerosisRajendra K Tangirala, Eric D Bischoff, Sean B Joseph, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5Mark R Herbert, Dana L Siegel, Lena Staszewski, et al.
Endocrinology|November 5, 2005
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Elife|July 14, 2016
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancerJames D Joseph, Beatrice Darimont, Wei Zhou, et al.
Pageof 3